Hemodialysis and hemoperfusion in a patient with an isolated phenytoin overdose

American Journal of Emergency Medicine

Volumn 24, Issue 6, 2006, Pages 748-749

  Miller, Michael A ^a,b   Crystal, Chad S ^a   Patel, Manish M ^c  

^a CARL R DARNALL ARMY MEDICAL CENTER   (United States)

^b Central Texas Poison Center   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; PHENYTOIN;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; ATAXIA; CASE REPORT; DISEASE COURSE; DISEASE SEVERITY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG OVERDOSE; HEMODIALYSIS; HEMOPERFUSION; HUMAN; HYDROXYLATION; LONG TERM CARE; MALE; NYSTAGMUS; PRIORITY JOURNAL;

ADULT; ANTICONVULSANTS; CHARCOAL; HEMOPERFUSION; HUMANS; MALE; PHENYTOIN; POISONING; RENAL DIALYSIS;

EID: 33748561515     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2006.02.011     Document Type: Article

References (3)

1. Rall T., and Schlerfer L. Drugs effective in the therapy of the epilepsies. In: Gilman A., Goodman L., Rall T., et al. (Eds). Goodman & Gilman's the pharmacological basis of therapeutics (1990), MacMillan, New York 436-444
2. Tozer T., and Winter M. Phenytoin. In: Evans W., Schentag J., and Jusko W. (Eds). Applied pharmacokinetics (1980), Appl Ther, Spokane 275-314
3. Sen S., Ratnaraj N., Davies N.A., Mookerjee R.P., Cooper C.E., Patsalos P.N., et al. Treatment of phenytoin toxicity by the molecular adsorbents recirculating system (MARS). Epilepsia 44 2 (2003) 265-267